PMC:7408073 / 63262-64499
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T397 | 64-69 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T398 | 368-372 | Body_part | denotes | body | http://purl.org/sig/ont/fma/fma256135 |
T399 | 374-379 | Body_part | denotes | Cells | http://purl.org/sig/ont/fma/fma68646 |
T400 | 506-512 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
T401 | 829-834 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T402 | 922-937 | Body_part | denotes | plasma membrane | http://purl.org/sig/ont/fma/fma63841 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T133 | 64-69 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2267 | 409-412 | Gene | denotes | ACE | Gene:59272 |
2268 | 416-420 | Gene | denotes | ACE2 | Gene:59272 |
2269 | 556-559 | Gene | denotes | ACE | Gene:59272 |
2270 | 564-568 | Gene | denotes | ACE2 | Gene:59272 |
2271 | 628-631 | Gene | denotes | ACE | Gene:59272 |
2272 | 636-640 | Gene | denotes | ACE2 | Gene:59272 |
2273 | 863-867 | Gene | denotes | ACE2 | Gene:59272 |
2274 | 868-871 | Gene | denotes | ACE | Gene:59272 |
2275 | 972-976 | Gene | denotes | ACE2 | Gene:59272 |
2276 | 1211-1215 | Gene | denotes | ACE2 | Gene:59272 |
2277 | 1182-1185 | Gene | denotes | MLN | Gene:4295 |
2278 | 0-9 | Chemical | denotes | CaNa2EDTA | |
2279 | 147-151 | Chemical | denotes | iron | MESH:D007501 |
2280 | 335-340 | Chemical | denotes | metal | MESH:D008670 |
2281 | 760-765 | Chemical | denotes | metal | MESH:D008670 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T794 | 64-69 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T795 | 64-69 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T796 | 82-83 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T797 | 374-379 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | Cells |
T798 | 506-512 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
T799 | 569-579 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
T800 | 829-834 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T801 | 922-928 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
T802 | 929-937 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
T803 | 1029-1034 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T53337 | 147-168 | Chemical | denotes | iron chelating agents | http://purl.obolibrary.org/obo/CHEBI_38157 |
T25372 | 147-151 | Chemical | denotes | iron | http://purl.obolibrary.org/obo/CHEBI_18248 |
T27100 | 152-168 | Chemical | denotes | chelating agents | http://purl.obolibrary.org/obo/CHEBI_38161 |
T154 | 200-208 | Chemical | denotes | zinc ion | http://purl.obolibrary.org/obo/CHEBI_27365 |
T155 | 200-204 | Chemical | denotes | zinc | http://purl.obolibrary.org/obo/CHEBI_27363|http://purl.obolibrary.org/obo/CHEBI_30185 |
T83733 | 205-208 | Chemical | denotes | ion | http://purl.obolibrary.org/obo/CHEBI_24870 |
T158 | 306-322 | Chemical | denotes | chelating agents | http://purl.obolibrary.org/obo/CHEBI_38161 |
T43731 | 341-345 | Chemical | denotes | ions | http://purl.obolibrary.org/obo/CHEBI_24870 |
T75520 | 354-358 | Chemical | denotes | zinc | http://purl.obolibrary.org/obo/CHEBI_27363|http://purl.obolibrary.org/obo/CHEBI_30185 |
T86735 | 466-470 | Chemical | denotes | zinc | http://purl.obolibrary.org/obo/CHEBI_27363|http://purl.obolibrary.org/obo/CHEBI_30185 |
T55396 | 528-532 | Chemical | denotes | zinc | http://purl.obolibrary.org/obo/CHEBI_27363|http://purl.obolibrary.org/obo/CHEBI_30185 |
T79616 | 704-708 | Chemical | denotes | zinc | http://purl.obolibrary.org/obo/CHEBI_27363|http://purl.obolibrary.org/obo/CHEBI_30185 |
T58337 | 766-782 | Chemical | denotes | chelating agents | http://purl.obolibrary.org/obo/CHEBI_38161 |
T33902 | 821-825 | Chemical | denotes | zinc | http://purl.obolibrary.org/obo/CHEBI_27363|http://purl.obolibrary.org/obo/CHEBI_30185 |
T76669 | 1076-1080 | Chemical | denotes | zinc | http://purl.obolibrary.org/obo/CHEBI_27363|http://purl.obolibrary.org/obo/CHEBI_30185 |
T173 | 1095-1104 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T19266 | 1149-1153 | Chemical | denotes | zinc | http://purl.obolibrary.org/obo/CHEBI_27363|http://purl.obolibrary.org/obo/CHEBI_30185 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T127 | 595-613 | http://purl.obolibrary.org/obo/GO_0044249 | denotes | cellular synthesis |
T128 | 604-613 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
T129 | 641-650 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
T130 | 872-881 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T303 | 0-105 | Sentence | denotes | CaNa2EDTA was approved by FDA in chelation therapy for lowering blood lead levels a long time ago (1953). |
T304 | 106-239 | Sentence | denotes | Then, different (commercially available) iron chelating agents, expected to work in chelating zinc ion as well, were approved by FDA. |
T305 | 240-373 | Sentence | denotes | Chelation therapy comprises intravenous or oral administration of chelating agents that remove metal ions such as zinc from the body. |
T306 | 374-471 | Sentence | denotes | Cells synthesising high amounts of ACE or ACE2 needs of high amounts of bioavailable (free) zinc. |
T307 | 472-614 | Sentence | denotes | Therefore, it is conceivable that plasma levels of free zinc may influence not only ACE and ACE2 activities but also their cellular synthesis. |
T308 | 615-746 | Sentence | denotes | Indeed, both ACE and ACE2 synthesis might be particularly sensitive to reduction of free zinc levels in case of their upregulation. |
T309 | 747-939 | Sentence | denotes | In addition, metal chelating agents, by limiting the availability of free zinc to cells, might have effects on both ACE2/ACE synthesis and conformation (when assembled on the plasma membrane). |
T310 | 940-1237 | Sentence | denotes | Indeed, the closed conformer of ACE2 homodimer that is the preferential conformation for virus binding [28], needs the presence of both zinc and substrate/inhibitor in the catalytic site [90], suggesting that zinc chelation (differently from MLN-4760) might also inhibit ACE2-mediated viral entry. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32708755-32132184-20678873 | 1044-1046 | 32132184 | denotes | 28 |